Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cyclerion Therapeutics, Inc. | Director | Common Stock | 20K | $67.9K | $3.40 | Nov 30, 2023 | Direct |
Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VYGR | Voyager Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Nov 30, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Director |
VYGR | Voyager Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Jul 25, 2022 | 1 | $0 | 4/A | Jul 27, 2022 | Director |
CYCN | Cyclerion Therapeutics, Inc. | Jul 25, 2022 | 0 | $0 | 3 | Jul 26, 2022 | Director |
VYGR | Voyager Therapeutics, Inc. | Jun 6, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
VYGR | Voyager Therapeutics, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |